Impact of a targeted hepatitis B vaccination program in Amsterdam, The Netherlands

Vaccine

Volumn 25, Issue 14, 2007, Pages 2698-2705

  van Houdt, Robin ^a   Sonder, Gerard J B ^a   Dukers, Nicole H T M ^a,b   Bovee, Lian P M J ^a   van den Hoek, Anneke ^a   Coutinho, Roel A ^b,c   Bruisten, Sylvia M ^a,b  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

HBV; Molecular epidemiology; Risk group vaccination

Indexed keywords

HEPATITIS B VACCINE; VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; DNA ISOLATION; DNA SEQUENCE; FEMALE; HEALTH PROGRAM; HEPATITIS B; HETEROSEXUALITY; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; NETHERLANDS; PHYLOGENY; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME; VACCINATION;

FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HOMOSEXUALITY, MALE; HUMANS; MALE; NETHERLANDS; PHYLOGENY; RETROSPECTIVE STUDIES; SUBSTANCE ABUSE, INTRAVENOUS; VACCINATION;

EID: 33947167284     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.06.058     Document Type: Article

References (20)

1. WHO. Hepatitis B fact sheet 204. http://www.who.int/mediacentre/factsheets/fs204/en/index.html (accessed August 9, 2005); 2000.
2. Koedijk F.D.H., Op de Coul E.L.M., and van de Laar M.J. Aangifte acute hepatitis B in 2003. Infect Bull 16 (2005) 15-17
3. Van Damme P.F., and Vorsters A. Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001. J Med Virol 67 3 (2002) 433-439
4. van Steenbergen J.E., Niesters H.G., Op de Coul E.L.M., van Doornum G.J., Osterhaus A.D., Leentvaar-Kuijpers A., et al. Molecular epidemiology of hepatitis B virus in Amsterdam 1992-1997. J Med Virol 66 2 (2002) 159-165
5. van Steenbergen J.E., and the Working Group Vaccination High-risk Groups Hepatitis B for The Netherlands. Results of an enhanced-outreach programme of hepatitis B vaccination in The Netherlands (1998-2000) among men who have sex with men, hard drug users, sex workers and heterosexual persons with multiple partners. J Hepatol 37 4 (2002) 507-513
6. van de Helm T. Project Vertrouwensvrouw voor Prostituees, 2002-2004 (2005), GGD, Amsterdam
7. Buster M.C., van Brussel G.H., and van den Brink W. Estimating the number of opiate users in Amsterdam by capture-recapture: the importance of case definition. Eur J Epidemiol 17 10 (2001) 935-942
8. GGD Amsterdam EDG. Amsterdams gezondheidsmonitor gezondheidsonderzoek 2004 (2006), GGD, Amsterdam [ISBN-10: 90-5348-140-0]
9. de Wit GA, Kretzschmar MEE, Smits LJM, Struijs JN, Postma MJ, van de Laar MJW, et al. Cost-effectiveness of national hepatitis B vaccination: interim report. National Institute of Public Health and the Environment 2000; RIVM Report 403505 004.
10. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 41 (1999) 95-98
11. Kumar S., Tamura K., and Nei M. MEGA 3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 5 2 (2004) 150-163
12. Norder H., Hammas B., Lofdahl S., Courouce A.M., and Magnius L.O. Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. J Gen Virol 73 Pt 5 (1992) 1201-1208
13. Edmunds W.J., Medley G.F., Nokes D.J., Hall A.J., and Whittle H.C. The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci 253 1337 (1993) 197-201
14. Kretzschmar M.F., de Wit G.A., Smits, and van de Laar M.J. Vaccination against hepatitis B in low endemic countries. Epidemiol Infect 128 2 (2002) 229-244
15. Hahne S., Ramsay M., Balogun K., Edmunds W.J., and Mortimer P. Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy. J Clin Virol 29 4 (2004) 211-220
16. Dukers N.H.T.M., Spaargaren J.F., Geskus R.B., Beijnen J.F., Coutinho R.A., and Fennema H.S. HIV incidence on the increase among homosexual men attending an Amsterdam sexually transmitted disease clinic: using a novel approach for detecting recent infections. AIDS 16 10 (2002) F19-F24
17. Dukers N.H., Goudsmit J., de Wit J.B., Prins M., Weverling G.J., and Coutinho R.A. Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection. AIDS 15 3 (2001) 369-378
18. van Ameijden E.J., and Coutinho R.A. Large decline in injecting drug use in Amsterdam, 1986-1998: explanatory mechanisms and determinants of injecting transitions. J Epidemiol Community Health 55 5 (2001) 356-363
19. Fisker N., Pedersen C., Lange M., Nguyen N.T., Nguyen K.T., Georgsen J., et al. Molecular epidemiology of hepatitis B virus infections in Denmark. J Clin Virol 31 1 (2004) 46-52
20. Zollner B. Surveillance of the molecular epidemiology of hepatitis B virus in industrialized countries: necessary despite low prevalence and an available, effective vaccine?. Clin Infect Dis 39 7 (2004) 953-954